检索结果-南通市图书馆

饲料与畜牧（新饲料） 2007年第4期 50-50页

作者： carsten Schulz Michael Wickert Claudia Kijora Johnny Ogunji bernhard Rennert 高俊(译)

为了评估碗豆蛋白作为奥尼罗非鱼幼鱼的饲料成分的效果，3个重复组的鱼被饲以4个不同蛋白来源的等氮（粗蛋白：421．1～427．5gk^-1干物质）和等能（总能：20．46～21．06MJ kg^-1干物质）日粮，实验进行8周。用0％（日粮100／0，对照... 详细信息

为了评估碗豆蛋白作为奥尼罗非鱼幼鱼的饲料成分的效果，3个重复组的鱼被饲以4个不同蛋白来源的等氮（粗蛋白：421．1～427．5gk^-1干物质）和等能（总能：20．46～21．06MJ kg^-1干物质）日粮，实验进行8周。用0％（日粮100／0，对照组），30％（日粮70／30），45％（日粮55／45）和600／0（日粮40／60）的分离碗豆蛋白粉按蛋白比例代替鱼粉来源的蛋白。

关键词：奥尼罗非鱼蛋白源豆蛋白日粮幼鱼评估饲料成分代替鱼粉

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欧洲参与式预算：潜力与挑战

中国治理评论

引用

中国治理评论 2022年第2期 145-159页

作者：伊夫·辛特默卡斯滕·赫茨伯格安雅·桡琪李荣鑫法国大学研究所巴黎第八大学柏林Nexus Institute 柏林洪堡大学北京大学政府管理学院

参与式预算自巴西“转移”到欧洲经历了一个高度差异化的过程。在巴西阿雷格里港（Porto Alegre），此种创新方式促进了巴西民主化与社会正义。但在欧洲，参与式预算依赖于多个复杂程序，因此有必要对其进行明确的方法学定义，以便能够... 详细信息

参与式预算自巴西“转移”到欧洲经历了一个高度差异化的过程。在巴西阿雷格里港（Porto Alegre），此种创新方式促进了巴西民主化与社会正义。但在欧洲，参与式预算依赖于多个复杂程序，因此有必要对其进行明确的方法学定义，以便能够连贯地比较案例间的差异，并构建理想类型以研究具体实验的多样性。我们提出的六种理想参与类型——适用于欧洲的阿雷格里港模式；具有组织利益的代理模式；地方和城市层面的社区基金模式；公共/私人谈判桌模式；公共财政咨询模式；以及近距离参与模式——较为深入地比较分析了个体案例间的差异，这些差异受到现有参与传统的高度影响。最为重要的是，通过进一步分析适用于欧洲的阿雷格里港模式和社区基金模式，我们发现，此类模式可以进一步促成“授权式参与治理”，这种治理模式——公民直接（或通过代表）分享决策权——正在发展为超越三种经典权力的第四种权力。

关键词：参与式预算欧洲案例预算模型潜力与挑战

来源：

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Alterations of Lymphoid Enhancer Factor-1 Isoform Expression in Solid Tumors and Acute Leukemias

引用

Acta biochimica et biophysica Sinica 2005年第3期37卷 173-180页

作者： Wenbing WANG Ping JI bjrn STEFFEN Ralf METZGER Paul M.SCHNEIDER Hartmut HALFTER Mark SCHRADER Wolfgang E.bERDEL Hubert SERVE carsten MLLER-TIDOW Institute of Life Sciences,Jiangsu University,Zhenjiang 212013.China Hematology and Oncology.and Neurology,Department of Medicine,University of Mnster,D-48129 Mnster,Germany Dematology of Visceral and Vascular Surgery,University of Cologne,D-50931 Cologne,Germany Department of Urolooy,Free University berlin,D-12200 berlin. InstituteofLifeSciences JiangsuUniversityZhenjiang212013China

Two major transcripts of lymphoid enhancer factor-1(LEF-1)have been *** longisoform with β-catenin binding domain functions as a transcriptional enhancer *** short isoformderives from an intronic promoter and exhibits dominant negative ***,alterations of LEF-1isoforms distribution have been described in colon *** the current study we employed a quantitativereal-time reverse transcription PCR method(TaqMan)to analyze expression of LEF-1 isoforms in a largecohort of human tumor(n=304)and tumor-free control samples(n=56).The highest expression level ofLEF-1 was found in carcinoma samples whereas brain cancer samples expressed *** of LEF-1 was different in distinct cancer *** example,the mRNA level of LEF-1 was lower in testiculartumor samples compared with tumor-free control *** epithelial cancers,significant LEF-1expression was also found in hematopoietic *** hematological malignancies,overall LEF-1 level washigher in lymphocytic leukemias compared with myeloid leukemias and normal ***,acute myeloid leukemia and acute lymphocytic leukemia showed a significantly increased fraction of theoncogenic LEF-1 compared with chronic lymphocytic leukemia and chromc myeloid *** together,these data suggest that LEF-1 is abundantly expressed in human tumors and the ratio of the oncogenic andthe dominant negative short isoform altered not only in carcinomas but also in leukemia.

关键词： AML β-catenin isoform lymphoid enhancer factor(LEF-1) solid tumor

来源：

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Latest development status of Qcells *** NEO technology

引用

第十九届中国太阳级硅及光伏发电研讨会(19th CSPV)

作者： J?rg W.Müller Ansgar Mette Stefan H?rnlein Ingmar H?ger Martin Schaper Kai Petter Matthias Jungh?nel Christian Klenke Anika Weihrauch Hans-Christoph Ploigt Ohjin Kwon Antje Sch?nmann Osama Tobail Kyunghun Kim Axel Schwabedissen Maximilian Kauert Klaus Duncker René H?nig Janko Cieslak Florian Stenzel bj?rn Faulwetter-Quandt Jessica Scharf Friederike Kersten benjamin Lee Sissel Tind Kristensen Olaf Schnelting carsten baer Martina Queck Gregor Zimmermann Matthias K?hler Nicole Lampa britta Pohl-Hampel Lorenzo burtone Larissa Niebergall Matthias Schütze Susanne Schulz Fabian Fertig Stefan Peters Markus Fischer Qcells Thalheim R&D Center(Hanwha Q CELLS GmbH)

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

音乐屋——奥尔堡创意中心

引用

城市环境设计 2020年第4期126卷 174-185页

作者：沃尔夫·狄·普瑞克斯 Marcelo bernardi Jesper bork bo Stjerne Hansen Roberta Jiraschek Daniel Krüger carsten Laursen Martin Oberascher Florian Pfeifer Robert Pippan Marita Schnepper Sigrid Svensson Eva Wolf Carola b?ker Moa Carlson Isak Foged Annina G?hwiler Patricia Gola Robin Heather Per Kruse Win Man Ruth Mandl Aline Müller Tenna Olsen Anke Pasolt Annemarie Pedersen Eva Ravnborg Carolin Schmitz-Remberg Tim Seidl Guro Sollid Michele Zanella Jan-Ruben Fischer Markus Pillhofer Markus baumann Robin Heather Anja Sorger bo Stjerne Thomsen Anna Wasserthal Philip Wilck blaine Lepp Talya Kozminsky Hannes Walzl Morten Grau Jensen Stephanie Neufeld Tyler bornstein Laura Githa Julia G?rtner Jenny Draxlbauer Duccio Malagamba Martin Schubert

项目大事记/CHRONOLOGY竞赛（第一名）/Competition （1st Place）:2003一期规划设计/Layout Planning Ho M I:2003—2005项目延期/Postponement of the Project:2006—2007二期规划设计/Start of Layout Planning Ho M II:2008二期动工/Start of Construction Ho M II:2010二期竣工/Completion Ho M II:2014项目参数/PROJECT DATA建筑净面积/Net Floor Area:17 637m2建筑毛面积/Gross Floor Area:20 257m2音乐厅/Concert Hall:1 298座/1 289 Seats

关键词：

来源：

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Axillary Surgery in breast Cancer - Primary Results of the INSEMA Trial

引用

The New England journal of medicine 2024年第12期46卷 2024 Dec 12页

作者： Toralf Reimer Angrit Stachs Kristina Veselinovic Thorsten Kühn Jörg Heil Silke Polata Frederik Marmé Thomas Müller Guido Hildebrandt David Krug beyhan Ataseven Roland Reitsamer Sylvia Ruth carsten Denkert Inga bekes Dirk-Michael Zahm Marc Thill Michael Golatta Johannes Holtschmidt Michael Knauer Valentina Nekljudova Sibylle Loibl bernd Gerber From the Department of Obstetrics and Gynecology University of Rostock Rostock Germany (T.R. A.S. B.G.) University Hospital Ulm Ulm Germany (K.V. I.B.) Hospital Esslingen Esslingen Germany (T.K.) University Hospital Heidelberg Heidelberg Germany (J. Heil M.G.) the breast Unit Sankt Elisabeth Hospital Heidelberg Germany (J. Heil M.G.) Evang. Waldkrankenhaus Spandau Berlin (S.P.) the Faculty of Medicine Mannheim Department of Obstetrics and Gynecology University of Heidelberg Mannheim Germany (F.M.) the Department of Obstetrics and Gynecology Hanau City Hospital Hanau Germany (T.M.) the Department of Radiation Oncology University Hospital Rostock Rostock Germany (G.H.) the Department of Radiotherapy and Radiation Oncology University Hospital Hamburg-Eppendorf (UKE) Hamburg Germany (D.K.) the Department of Radiation Oncology University Medical Center Schleswig-Holstein Kiel Germany (D.K.) Medical School and University Medical Center OWL Department of Gynecology and Obstetrics Bielefeld University Klinikum Lippe Detmold Germany (B.A.) Salzburg Regional Hospital Salzburg Austria (R.R.) Johanniter-Hospital Genthin-Stendal Genthin Germany (S.R.) the Institute of Pathology Philipps-University Marburg and University Hospital Marburg (UKGM) Marburg Germany (C.D.) breast Center St. Gallen Kantonsspital St. Gallen Switzerland (I.B.) SRH Wald-Klinikum Gera Gera Germany (D.-M.Z.) the Department of Gynecology and Gynecologic Oncology Agaplesion Markus Hospital Frankfurt am Main Germany (M.T.) the German breast Group Neu-Isenburg Germany (J. Holtschmidt V.N. S.L.) and the Tumor and breast Center Eastern Switzerland St. Gallen Switzerland (M.K.).

bACKGROUND:Whether surgical axillary staging as part of breast-conserving therapy can be omitted without compromising survival has remained unclear.METHODS:In this prospective, randomized, noninferiority trial, we investigated the omission of axillary surgery as compared with sentinel-lymph-node biopsy in patients with clinically node-negative invasive breast cancer staged as T1 or T2 (tumor size, ≤5 cm) who were scheduled to undergo breast-conserving surgery. We report here the per-protocol analysis of invasive disease-free survival (the primary efficacy outcome). To show the noninferiority of the omission of axillary surgery, the 5-year invasive disease-free survival rate had to be at least 85%, and the upper limit of the confidence interval for the hazard ratio for invasive disease or death had to be below 1.271.RESULTS:A total of 5502 eligible patients (90% with clinical T1 cancer and 79% with pathological T1 cancer) underwent randomization in a 1:4 ratio. The per-protocol population included 4858 patients; 962 were assigned to undergo treatment without axillary surgery (the surgery-omission group), and 3896 to undergo sentinel-lymph-node biopsy (the surgery group). The median follow-up was 73.6 months. The estimated 5-year invasive disease-free survival rate was 91.9% (95% confidence interval [CI], 89.9 to 93.5) among patients in the surgery-omission group and 91.7% (95% CI, 90.8 to 92.6) among patients in the surgery group, with a hazard ratio of 0.91 (95% CI, 0.73 to 1.14), which was below the prespecified noninferiority margin. The analysis of the first primary-outcome events (occurrence or recurrence of invasive disease or death from any cause), which occurred in a total of 525 patients (10.8%), showed apparent differences between the surgery-omission group and the surgery group in the incidence of axillary recurrence (1.0% vs. 0.3%) and death (1.4% vs. 2.4%). The safety analysis indicates that patients in the surgery-omission group had a lower incidence

关键词： trial surgery axillary breast cancer-primary insema results

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：